Quality Care

IntelliSite is designed to streamline workflows, enhance diagnostic confidence, facilitate collaboration, integrate AI and increase the efficiency of pathology labs.

Also, US-based Pearl has received regulatory approvals to market its AI diagnostic tool for dental radiology in Australia and New Zealand.

A new AI screening tool has been trained to identify 14 of the most common retinal abnormalities.

The SoftVue system is intended to be used in addition to digital mammograms to screen for cancer among patients with dense breast tissue.

Clinical research is set to verify the technology's effectiveness in estimating abnormal heart movements.

Philips Pediatric Coaching helps children feel more comfortable with MRI scans, avoiding the need for sedation or general anesthesia.

Dr. Nadia Chaudhri, a neuroscientist and professor, shared her experience with ovarian cancer on Twitter, showing how social media can be a powerful tool to connect and educate on chronic or serious illnesses.

A study by Imperial College London found the therapy was more effective in treating stress, anxiety and PTSD than popular meditation apps.

As physician workloads in increase, technology is helping providers efficiently connect with pharma reps.

The latest approval marks DreaMed’s fourth clearance from the Food and Drug Administration.